Tools
Stock profile

BAXTER INTERNATIONAL INC (BAX)

BAX · Latest close $26.16 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$26.16
As of Nov 18, 2026
Tracked funds holding
9 of 149
2026 Q2 13F filings
Opened / added
0 / 4
vs previous quarter
Trimmed / exited
4
vs previous quarter

BAXTER INTERNATIONAL INC (BAX) is held by 9 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 4 funds adding and 4 funds trimming or exiting versus the previous quarter. Latest close $26.16 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: none in the last 90 days · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Government relations · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

Pzena Investment Management · Investment Management Associates · Hillman Capital Management — 9 tracked funds hold BAX. See all holders.

Insider and Congress activity

No insider open-market activity or Congress trades reported for this stock in the recent window. Insider trading · Politician trading.

Often held alongside

Orion S.A. (OEC) · TARGET CORP (TGT) · Avantor, Inc. (AVTR) · NOV Inc. (NOV) · OSHKOSH CORP (OSK) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Pzena Investment Management4.09%65,295,393ADDED (+1.2%) Q3 filed Oct 30
Investment Management Associates3.94%900,843ADDED (+15.7%) Q3 filed Oct 29
Hillman Capital Management3.64%236,032TRIMMED (-4.6%) Q3 filed Nov 16
Greenhaven Associates3.52%14,285,228TRIMMED (-0.2%) Q3 filed Oct 26
First Pacific Advisors2.01%7,618,145ADDED (+13.7%) Q3 filed Nov 12
Dodge & Cox Funds0.65%58,386,345ADDED (+2.0%) Q3 filed Nov 13
Tweedy Browne0.02%9,479TRIMMED (-2.7%) Q3 filed Nov 4
Aequim Alternative Investments0.02%60,000HELD Q3 filed Nov 12
Mairs & Power Funds<0.01%12,532TRIMMED (-44.4%) Q3 filed Nov 16

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: +18.8% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

36.5714.972024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding692 of 8,857 filers
Long-only filers among them685
Change vs 2026 Q1+36 net · 646 entered · 610 exited
Shares reported, all filers555,580,333
Reported value, all filers$11.7B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNYSE
IndustrySurgical & Medical Instruments & Apparatus (SIC 3841)
Revenue · FY2025$11.2B
Net income · FY2025$-957.0M
Total assets · FY2025$20.1B
Shares outstanding517,348,188
Market cap (at latest close)$13.5B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Oct 22, 2026.

Short interest

Shares short · Oct 15, 202623,765,665
Share of shares outstanding4.59%
Days to cover4.19

Shares short at recent settlements — Jul 31, 2026: 32.7M · Aug 14, 2026: 23.9M · Aug 31, 2026: 23.3M · Sep 15, 2026: 23.2M · Sep 30, 2026: 24.4M · Oct 15, 2026: 23.8M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Oct 22, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 2K · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Oct 22, 2026.

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the last 90 days.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
May 18, 2026STEPHEN N. OESTERLE REV TRUSTFormer Affiliate36,347$645.2KMay 18, 2026SEC filing
Sep 16, 2024Stevens BrianOfficer976$39.0KSep 16, 2024SEC filing
Sep 13, 2024Stevens BrianOfficer16,063$639.5KSep 13, 2024SEC filing
Mar 1, 2024JEANNE MASONOfficer64,488$2.6MMar 1, 2024SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Jun 5, 2026FMR LLCSC 13G/A52,972,914.2710.3%May 29, 2026SEC filing
May 6, 2026FMR LLCSC 13G/A46,264,804.289.0%Mar 31, 2026SEC filing
Apr 29, 2026Vanguard Capital ManagementSC 13G38,033,9077.4%Mar 31, 2026SEC filing
Apr 27, 2026BlackRock, Inc.SC 13G/A33,109,8526.4%Mar 31, 2026SEC filing
Apr 21, 2026PZENA INVESTMENT MANAGEMENT LLCSC 13G/A65,347,62112.7%Mar 31, 2026SEC filing
Mar 26, 2026The Vanguard GroupSC 13G/A00.0%Mar 13, 2026SEC filing
Feb 5, 2026FMR LLCSC 13G34,811,770.046.8%Dec 31, 2025SEC filing
Jan 21, 2026BlackRock Portfolio Management LLCSC 13G/A44,925,3418.7%Dec 31, 2025SEC filing
Jan 21, 2026PZENA INVESTMENT MANAGEMENT LLCSC 13G/A70,866,04913.8%Dec 31, 2025SEC filing
Nov 13, 2025Dodge & CoxSC 13G/A57,396,37011.2%Sep 30, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Government relations

Lobbying: 30 Lobbying Disclosure Act filings named this company as client, 2012–2026; most common issues: Health Issues (28), Medicare/Medicaid (27).

Federal contracts: $56.4M in obligated amounts, fiscal years 2021–2026.

Fiscal yearObligated amount
FY2021$1.7M
FY2022$28.6M
FY2023$23.8M
FY2024$2.3M
FY2025$0
FY2026$0

Largest awards collected

Award IDAgencyAmountStart
75A50120C00175Department of Health and Human Services$29.9MSep 17, 2020
75A50323C00004Department of Health and Human Services$9.2MMar 1, 2023
75A50120C00120Department of Health and Human Services$5.4MJun 1, 2020
75A50121P00049Department of Health and Human Services$1.7MMay 14, 2021
75A50121C00049Department of Health and Human Services$1.6MApr 30, 2021

Lobbying filings are matched by company core name; a filing can match more than one ticker. Contract amounts are obligated amounts (money committed, not money spent), matched by recipient name — contracts under a subsidiary’s name can be missed. Sources: Senate Lobbying Disclosure Act filings; USAspending.gov. See Methodology.

Screens & lenses

Chart Signals

· Monthly Uptrend — Price above its 12-month moving average

· Top Relative Strength — Top 20% of the universe by 6-month return

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together540.0%-5.6%+3.9%-9.4%
Share count tripled (3x)333.3%-4.2%+6.5%-10.8%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Also held by the tracked funds that hold BAX — ranked by lift, the co-holding pattern described in Methodology: Orion S.A. (OEC) · TARGET CORP (TGT) · Avantor, Inc. (AVTR) · NOV Inc. (NOV) · OSHKOSH CORP (OSK) · DIAGEO PLC (DEO) · ARROW ELECTRONICS, INC. (ARW) · Baidu, Inc. (BIDU).

Recent 8-K filings

FiledItemsSource
Oct 29, 20262.02 Results of Operations and Financial Condition · 8.01 Other Events · 9.01 Financial Statements and ExhibitsSEC filing
Aug 19, 20265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and ExhibitsSEC filing
Aug 18, 20261.01 Entry into a Material Definitive Agreement · 8.01 Other Events · 9.01 Financial Statements and ExhibitsSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

Orion S.A. (OEC) · Track Record: how the signals scored · Practice timing on BAX

One email a week: the week’s new filings and research. Subscribe free

← BATRK  ·  BAYRY →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.